This study was performed to investigate potential bioactive secondary metabolites from the leaves of Acacia mearnsii, a forest waste product in China. The polyphenol constituents and bioactivity of crude extract (L) and semi purified fractions (L1-L4) were examined. The L and L1-L4 showed qualitative and quantitative differences in their phenolic content, antioxidant activities and the activities against inflammation-related genes such as the inducible forms of COX-2, iNOS, and the pro-inflammatory IL in lipopolysaccharide (LPS)-stimulated mouse macrophage cell line RAW 264.7. All the fractions depressed reactive oxygen species (ROS) in LPS-stimulated RAW 264.7 macrophage cells, and (except L2) inhibited the release of nitric oxide (NO). Fractions L3 and L4 significantly inhibited the mRNA expression levels of the anti-inflammatory cytokine IL-1β, COX-2, iNOS, and IL-6. In addition, L4 (1.8 g obtained from 5 g crude leaves extract) which contained 646.6 mg/g gallic acid equivalent total phenolic content and consisted of primarily proanthocyanidins (12.6 mg/g as procyanidin B2 equivalent by the DMAC assay) showed the best activity in all the assays. Results indicate that A. mearnsii leaves, a forest waste product, could be a valuable natural source of anti-inflammatory and functional components related to human health.
Acacia mearnsii (common name: Black Wattle), native to Australia, is an important plantation species for tannin production and woodchip industries [1] . In 1984 a joint research project on black wattle was established between the Chinese Academy of Forestry (CAF) and the Australian Center for International Agricultural Research (ACIAR) to accelerate development of black wattle plantations in China [2] .
The bark extract of Acacia is traditionally used in the leather tanning industry, but current research on the composition and biological activity of the bark extract has suggested applications in health and medicine as well [3a, 3b] . The wattle bark is an important industrial source of proanthocyanidins (PAC) which are reported to constitute 68% by weight of bark extract, and are valued for their health-related applications including antioxidant and antitumor effects, hair growth promotion, antihypertension, and antiallergic properties [4] .
In recent studies, mouse models have been used to evaluate antiobesity, anti-diabetic [5a] , lipase inhibition and glucosidase activities [5b] of Acacia bark extract. A. mearnsii polyphenols demonstrated efficacy for alleviating metabolic syndrome [5a] , inhibiting lipase and glucosidase activities [5b] and alleviating itching associated with atopic dermatitis, by preventing skin dryness [5c]. Although A. mearnsii bark have been extensively studied for phytochemical composition and biological activities, minimal research has been conducted on the leaves. Reportedly, leaves accumulate flavonoids including myricitrin, quercitrin, mearnsitrin, catechin, gallocatechin, and leuco-delphinidin tannin [6a-6c] .
The aim of this study was to investigate A. mearnsii leaves grown in China, to determine phytochemical composition, antioxidant and anti-inflammatory properties, and potential as a low-cost healthpromoting resource for human and animal food industries. In our present work, Acacia mearnsii dried leaves were extracted with methanol to afford the crude extracts. The leaves crude extract (L) was fractionated on a Sephadex LH-20 column to afford 4 fractions: L1-L4. Crude extracts and their individual fractions were investigated for phytochemical content, compound characterization, antioxidant capacity, and anti-inflammatory activity.
Results of chemical assays, shown in Table 1 , indicated that L contained 434.9 mg gallic acid equivalent (GAE)/g total phenolic (TP), 29.6 mg isoquercitrin equivalent (IQE)/g total flavonoid (TF), and 3.8 mg procyanidin B2 equivalent (B2E)/g total proanthocyanidins (PAC). Fractions L2, L3, and L4 did not differ significantly in TP, while all were higher than L1 and L. Fraction L2 showed the highest level of TF. L3 and L4 did not differ in PAC content. The TP in L and its fractions L1-L4 correlated with PAC content (R 2 = 0.82, P < 0.05), but not with TF (R 2 = 0.04, P > 0.05).
The radical scavenging antioxidant capacity was determined by ABTS assay; a widely used spectrophotometric assay for plant extracts [7] . L showed antioxidant capacity of 2.3 mmol Trolox equivalent (TE)/g. The antioxidant capacity increased in individual NPC Natural Product Communications 2016 Vol. 11 No. 5 649 -653 fractions (2.9, 4.9, 6.3, and 7.0 mmol TE/g for L1, L2, L3, and L4, respectively) ( Table 1) . These activities were moderately correlated with TP (R 2 = 0.64, P < 0.05).
Normal phase HPLC with fluorescence detection was able to separate proanthocyanidin molecules according to their degree of polymerization (DP). As expected, the acetone-eluted fractions (L4) accumulated the higher percentages of polymerized PAC, while water (L1) and methanol fractions (L2 & L3) contained monomeric and oligomeric PAC with DP≤5 ( Table 2 ). The major phenolic constituents identified in A. mearnsii leaves by LC-ESI-IT-TOF-MS are listed in Table 3 . Figure 1A shows the effect of A. mearnsii leaves extract and fractions on the inhibition of intracellular LPSinduced ROS generation. The positive control dexamethasone (DEX) lowered ROS production nearly to nominal levels. There were varying levels of intracellular ROS inhibition among A. mearnsii leaves extract and fractions ( Figure 1A ). L and its fractions (L1-L4) all significantly inhibited ROS production in RAW 264.7 macrophages by a statistically significant amount (P < 0.001), indicating that A. mearnsii leaf components can effectively reduce ROS production back to their non-stimulated state.
The oxidative nitric oxide pathway culminates in the generation of nitrite, which can be quantitatively measured from culture media using the Griess reagent. Nitric oxide (NO) production was monitored in macrophage cells stimulated by LPS for 24 h. LPS (1 μg/mL) evoked a 2.0-fold induction of nitrite production versus 
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Natural Product Communications Vol. 11 (5) 2016 651 the naive control, and this induction was inhibited by the positive control, DEX, to baseline levels (P < 0.001). A. mearnsii L extract and L1, L3 & L4 fractions reduced NO production by a statistically significant amount (P < 0.001) ( Figure 1B) . Fractions L3 and L4 were able to reduce the NO levels back to non-stimulated levels.
The NO reduction levels achieved by A. mearnsii extracts and fractions exhibited a positive correlation with in vitro ROS inhibition capability (R 2 = 0.69, P < 0.001).
Examination of the cytotoxicity of the samples in macrophages by MTT indicated that up to 100 μg/mL, none of the tested samples affected the viability of the RAW 264.7 (Data not shown). Therefore, inhibition of LPS induced oxidative stress (via ROS or NO production) was not the result of a cytotoxic effect.
LPS stimulation in mammalian cells can lead to release of proinflammatory cytokines and in turn activate inflammatory cascades including cytokines, lipid mediators and adhesion molecules such as interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and interleukin-6 (IL-6). These four wellknown genetic biomarkers involved in the inflammatory response were investigated in vitro in LPS-stimulated murine RAW 264.7 macrophage model. The in vitro experiments were designed to quantify the relative amount of transcripts for target genes within the total RNA in individual cell batches treated with A. mearnsii leaf extract and fractions. For each assay, three control sets were monitored. The negative control (no LPS treatment) maintained a constant amount of transcripts for all constitutively expressed genes and served as a reference baseline; the induction control (treated with LPS) showed the maximum up-regulation of the marker genes; and the positive control (treated with LPS and DEX) served as a reference for the effectiveness of the assay.
In vitro experiments showed that L and L1-L4 almost completely suppressed the expression of acute pro-inflammatory genes 1L-1β (Figure 2A) , a positive marker for inflammation, metabolic syndrome, and immune suppression. In addition, some fractions were able to inhibit the LPS-elicited transcription of inducible proinflammatory enzyme coding genes like COX-2, iNOS and IL-6 ( Figure 2B , C and D, respectively). The iNOS expression inhibition by L and L1-L4 correlated positively with inhibition of the NO generation by L and L1-L4 (R 2 = 0.67, P < 0.01). The L4 fraction had the highest anti-inflammatory activity (significant at P < 0.001) in the four assays performed here. The inhibitory effects were almost 100%, and in all targets we observed stronger suppression than in the positive control (L4 fraction at 50 μg/mL 0.075 ± 0.060 for IL-1β; 0.045 ± 0.038 for COX-2; 0.079 ± 0.071 for iNOS and 0.113 ± 0.061 for IL-6; DEX at 10 μM 0.241 ± 0.126 for IL-1β; 0.252 ± 0.066 for COX-2; 0.176 ± 0.069 for iNOS and 0.320 ± 0.113 for IL-6, respectively). Our data demonstrate that L4 suppressed all biomarkers of inflammation tested. In a dose-response experiment (Figure 3) , L4 inhibited the LPS-induced activation of IL-Iβ, COX-2 and iNOS in a dose-dependent manner. L4 was able to inhibit the LPS-induced activation of all biomarkers of inflammation tested by more than 50% at 50 μg/mL and 100 μg/mL concentrations.
Previous research on bioactivity of A. mearnsii bark has been reported; however, to the best of our knowledge, there is no data on the bioactivity of leaves, which are currently treated as a waste product from the forest industry in China. This report documents the antioxidant and anti-inflammatory activities of Acacia mearnsii leaves, an abundant, easier to harvest, and a more renewable resource for polyphenol rich bioactive extracts. Our study reports that A. mearnsii leaves, a low-cost raw material resource, is a valuable source of natural antioxidants with anti-inflammatory activities, and can have strong potential in the food and food supplement industry as a resource for health promotingpolyphenolics. Air-dried leaves were ground into fine powders of 30-80 mesh.
Preparation of Crude Extract and Fractions:
Powdered leaf sample (30 g) was extracted twice with 500 mL of acidified 80% aqueous methanol (0.1% TFA) and then with 500 mL of 70% aqueous acetone. Extracts were combined, filtered, organic solvents vacuum evaporated and remaining aqueous extract was lyophilized to afford the crude extract (L). L (5 g) was dissolved in 60% aqueous methanol and loaded onto a column packed with hydrated Sephadex LH-20 (25 cm × 3 cm). Elution started with 3 L of water (L1, 1.72 g), then 2 L 60% aqueous methanol (L2, 0.29 g; L3, 0.35 g), and finally 500 mL 70% aqueous acetone (L4, 1.81 g).
Chemical Assays Total Phenolic Content:
Total phenolic (TP) concentrations were measured spectrophotometrically using a microplate-adapted Folin-Ciocalteu assay [9] . Results were standardized against a gallic acid curve and expressed as gallic acid equivalents (mg GAE/ g dry sample).
Total Flavonoid Content:
The flavonoid (TF) content was determined spectrophotometrically by the AlCl 3 method [10] with modifications. Briefly, 100 μL of the sample or standard was added to 100 μL of 2% AlCl 3 solution in each well of a 96-well plate, mixed well and left at 20 °C for 1 h. The absorbance was then read at 415 nm against a blank. Isoquercetin was used for the calibration curve and results are expressed as isoquercetin equivalent (μg IQE/g dry sample).
Total Proanthocyanidin Content:
Total proanthocyanidins (PAC) was quantified colorimetrically using the DMAC method in a 96-well plate against a standard curve constructed with procyanin B2 standard as previously described [11] . Concentration of total PAC was calculated as procyanidin B2 equivalents (mg B2/g dry sample).
HPLC-FLD and LCMS-IT-TOF Analyses:
HPLC Analysis for PAC was conducted using an Agilent 1200 HPLC with fluorescence detector (FLD). PAC were separated according to Wallace and Giusti [12] , using a Develosil Diol normal phase column (250 mm x 4.6 mm x 5 µm, Phenomenex, Torrance, CA). Fluorescence detection was set at 230 nm excitation at and 321 nm emission. Four concentrations of procyanidin B2 standard reference were prepared at 0.5, 0.25, 0.125, and 0.05 mg/mL and 5 µL was used as external standards, and total PAC concentration was calculated as mg/g procyanidin B2, and presented as percentage of total.
LC-MS analysis was performed using a Shimadzu LC-MS-IT-TOF instrument (Shimadzu, Tokyo, Japan) with a Shim-pack XR-ODS column (50 mm x 3.0 mm x 2.2 µm), ESI in the negative ionization mode, as described earlier [13] . Compounds were characterized and identified by their MS, MS/MS spectra in comparison with literature, and with available reference samples.
ABTS Antioxidant Activity:
The ABTS antioxidant activity assay was performed as described earlier [14] . The antioxidant activities were reported in Trolox equivalents (mmol TE/g dry sample).
Anti-inflammatory Activity in RAW 264.7 Cells
Macrophage Cell Culture: RAW 264.7, a mouse macrophage cell line (ATCC TIB-71, obtained from American Type Culture Collection; Livingstone, MT, USA), was maintained in DMEM, supplemented with 100 IU/mL penicillin, 100 µg/mL streptomycin, and 10% fetal bovine serum at a density not exceeding 5x10 5 cells/mL and maintained at 37 °C in a humidified incubator with 5% CO 2 [15] .
Cell Viability Assay and Dose Range Determination Studies:
RAW 264.7 viability was measured by the MTT [3-(4, 5dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide] assay in triplicate and quantified spectrophotometrically at 550 nm. The concentrations of test reagents that showed no changes in cell viability compared with that vehicle (DMSO) were selected for further studies [15] .
Reactive Oxygen Species (ROS) Assay:
In vitro ROS generation was assayed by a fluorescent dye protocol [16] . RAW 264.7 cells were incubated overnight in a 96-well plate. Cells were charged with 1 μL of 1 mg/mL DCFDA, prepared fresh daily in DMSO for 30 min. Fluorescent medium was aspirated, and cells were exposed to 1 μL of 10 mg/mL extract/fraction until a concentration of 50 µg/mL was reached in each well and 1 μL 200 µg/mL of LPS and incubated for 24 h. The fluorescence was measured at 485 nm (excitation) and 520 nm (emission) on a microplate reader. The known antioxidant dexamethasone (DEX) was used as a positive control. The experiments were performed in triplicate on the same plate and repeated at least 2 times.
Nitric Oxide (NO) Radical Inhibition Assay:
The abilities of test samples to inhibit nitric oxide radical formation in activated macrophages were determined by a colorimetric assay [17] . Cells were seeded in 96-well plates 24 h prior to treatment. The cells were then treated with A. mearnsii extracts and fractions at 50 µg/mL for 1 h before elicitation with LPS at 1 µg/mL for an additional 4 h. Subsequently, 100 µL of culture media was mixed with 100 µL of Griess reagent (1% sulfanilamide and 0.1% naphthylethylenediamine in 2% phosphoric acid), and the mixture was incubated at room temperature for 10 min and then read on a microplate reader at 540 nm. Absorbances were compared against a calibration curve created with serial dilutions of sodium nitrite (R 2 = 0.999).
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Biomarkers of Inflammation by Gene Expression Analysis:
RAW 264.7 cells were subcultured by TrypLE TM when dishes reached up to 90% confluence with a 1:5 ratio in fresh medium. Cells were seeded in 24-well plates (5 × 10 5 cells/well) 24 h prior to treatment. The cells were then treated with A. mearnsii crude extract (L) and fractions (L1-L4) at predetermined doses for 1 h before elicitation with LPS at 1 µg/mL for an additional 4 h. For every experiment, one positive control (cells treated with DEX, at 10 µM) and one negative control (cells treatment with vehicle) were included. Three replicates were made for both the treatments and the controls. At the end of the treatment period, cells were harvested in TRIzol reagent for subsequent cellular RNA extraction.
Total RNA Extraction, Purification, and cDNA Synthesis: Total RNA was isolated from the cells using TRIzol reagent following instructions of the manufacturer. RNA was quantified spectrophotometrically using the SynergyH1/Take 3 (BioTek, Winooski, VT, USA). The cDNA was synthesized using 2 µg of RNA for each sample using commercially available high-capacity cDNA Reverse Transcription kit, following the manufacturer's protocol on an ABI GeneAMP 9700.
Quantitative PCR Analysis:
The resulting cDNA was amplified by real-time quantitative PCR using SYBR green PCR Master Mix. Quantitative PCR (qPCR) amplifications were performed on an ABI 7500 fast real time PCR as described earlier [15] . All analyses were performed at least 3 times.
Statistical Analysis: Statistical analyses were performed using Prism 6.0 (GraphPad Software, San Diego, CA, USA). Data were analyzed by one-way ANOVA with treatment as a factor. Post hoc analyses of differences between individual experimental groups were made using the Dunnett's multiple comparison tests. Results are expressed as means ± SEM.
